- Takeda Oncology
- Schering-Plough Corp.
- Merck & Co. Inc.
- Johnson & Johnson
- GlaxoSmithKline PLC
- Scios Inc.
- Ortho Biotech Products LP
- Biogen Inc.
- Schering AG
- The Medicines Co.
- Takeda Pharmaceuticals International GmbH
- Amgen Inc.
- Novartis AG
- NPS Pharmaceuticals Inc.
- Alliance Pharmaceutical Corp.
- Praecis Pharmaceuticals Inc.
- Cubist Pharmaceuticals Inc.
- Icos Corp.
- Celgene Corp.
- Corixa Corp.
- Marina Biotech Inc.
- GSK to sell Millennium's Integrilin in Europe
- Scios licenses Natrecor to GlaxoSmithKline
- GlaxoSmithKline acquires Sanofi-Synthelabo's antithrombotics
- Millennium in giant cancer deal with Ortho Biotech
- The Medicines Co., Nycomed in Angiomax agreement
- Nycomed takes on European rights to NPS's Preos; all rights later returned
- Nycomed to develop PFC's Oxygent in Europe
- Schering, Praecis terminate Plenaxis deal
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.